My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)

1.480 +0.170 (+12.98%)
Streaming Delayed Price Updated: 3:02 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ironwood Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Wondering what's happening in today's after-hours session?
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
Why American Eagle Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Wondering what's happening in today's after-hours session?
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
Ironwood (IRWD) Q2 EPS Jumps 600%
Via The Motley Fool
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Reports Strong Q2 2025 Earnings with 37.5% Revenue Beat and 250% EPS Surge
Ironwood Pharmaceuticals Q2 2025 earnings beat estimates with $85.24M revenue and $0.14 EPS, driven by LINZESS growth and pipeline progress. Shares surged 19.25% pre-market. 
Via Chartmill
Topics Earnings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
What's going on in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Get insights into the top gainers and losers of Friday's after-hours session.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Friday's after hours session: top gainers and losers
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call
The drugmaker’s first-quarter revenue of $41.1 million came in well below the consensus estimate of $56.7 million, attributed to changes in AbbVie’s gross-to-net rebate reserves. 
Via Stocktwits
Topics Earnings
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
 
Via Benzinga
Which stocks are moving on Monday?
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug
Ironwood must run a new Phase 3 trial after FDA talks, delaying its SBS drug approval despite strong results from prior studies. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Crude Oil Moves Lower; M&T Bank Earnings Miss Views
 
Via Benzinga
Topics Earnings
Gapping stocks in Monday's session
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. 
Via Chartmill
These stocks are moving in today's pre-market session
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
Nasdaq Surges 2%; Goldman Sachs Posts Upbeat Earnings
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.